| Literature DB >> 1989146 |
O Salvatierra1, J McVicar, J Melzer, W Amend, F Vincenti, S Tomlanovich, R Husing, J Rabkin, M Garovoy.
Abstract
A combined DST-sequential CyA therapy protocol has been described that results in optimum graft survival for 1- and 2-haplotype mismatched living related donor-recipient combinations. In addition to the excellent graft survival obtained through 4 years, lower prednisone and CyA dosage levels are achieved with significantly decreased infection rates during the posttransplant period.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1989146
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066